Brent Saun­ders piv­ots from Al­ler­gan sale to a $460M SPAC, mak­ing him an overnight play­er in one of the hottest mon­ey-rais­ing gam­bits in biotech

It was on­ly a mat­ter of time be­fore Brent Saun­ders start­ed wheel­ing and deal­ing again. And what bet­ter ve­hi­cle to choose for his first se­ri­ous en­deav­or than a blank check com­pa­ny?

All the rage in biotech fi­nan­cial ser­vices these days, Saun­ders has formed a spe­cial pur­pose ac­qui­si­tion com­pa­ny called Ves­per Health­care Ac­qui­si­tion aimed at rais­ing $460 mil­lion plus for some bio­phar­ma com­pa­ny look­ing to gin cash and quick recog­ni­tion with a leap in­to Nas­daq.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER